Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jun 17, 2013 (13 years ago)

Enteric Coated Aspirin

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Mix-Up: A complaint from a pharmacist was received that the entire contents of 1 bottle labeled as Rugby label Enteric Coated Aspirin 81 mg Tablets actually contained Acetaminophen 500 mg Tablets.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

ENTERIC COATED ASPIRIN (NSAID), 81 mg, 120-count tablets per bottle, distributed by: Rugby Laboratories, Inc., Duluth, Georgia 30097, NDC 0536-3086-41, UPC 3 0536-3086-41 9.

Affected NDC 0536-3086-41

Compare with the code on your package — it is the most precise check available.

Drug: Aspirin Category: Pain Relief & OTC Medication

Recalling firm
Advance Pharmaceutical Inc
NDC code
0536-3086-41
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-919-2013 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Aspirin recalls

See all
Class II · Moderate risk

Aspirin Chewable tablet 81 mg

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Ongoing Packaging defect Safecor Health, LLC NDC 48433-129-01 D-0058-2025
Class I · High risk

Healthy Living Acetaminophen

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Ongoing Labeling / mix-up Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class II · Moderate risk

HPC Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62969-242-00 D-0538-2022

Other recalls by Advance Pharmaceutical Inc

All 2013 recalls